ReviewInternational journal of molecular sciences2025

Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds.

Jiani Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.